美国 · SEC FORM 4
HCA Healthcare, Inc.
HCA · NYSE · CIK 0000860730 · Healthcare · Medical Care Facilities
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
0 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-07-25 · Elcan Patricia F.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 4,884,718
- 上期报告
- 6,479,985
- 日均成交量
- 1,594,337
- 回补天数
- 3.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-07-25 | Elcan Patricia F | 买入 (P) | Common Stock, par value $0.01 per share | 325 | USD 198.66 | USD 64,564 | SEC 申报 ↗ |
| 2022-05-02 | FRIST THOMAS F JR | 买入 (P) | Common Stock, par value $0.01 per share | 89,100 | USD 211.93 | USD 18,883,001 | SEC 申报 ↗ |
| 2022-04-29 | McAlevey Michael R | 买入 (P) | Common Stock | 1,110 | USD 218.56 | USD 242,602 | SEC 申报 ↗ |
| 2022-04-28 | Smith Andrea B | 买入 (P) | Common Stock | 1,160 | USD 213.63 | USD 247,811 | SEC 申报 ↗ |
Form 4 申报证据
67 transaction lines in the latest 365-day window; 880 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael R | J (J) | Common Stock | 7,769 | USD 429.00 | USD 3,332,901 | SEC 申报 ↗ |
| 2026-05-07 | Marks Mike A | 赠与 (G) | Common Stock | 3,336 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Smith Andrea B | 奖励／授予 (A) | Common Stock | 509 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael R | J (J) | Common Stock | 7,769 | USD 429.00 | USD 3,332,901 | SEC 申报 ↗ |
| 2026-05-07 | Marks Mike A | 赠与 (G) | Common Stock | 3,336 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Smith Andrea B | 奖励／授予 (A) | Common Stock | 509 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Riley Wayne Joseph | 奖励／授予 (A) | Common Stock | 509 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | MICHELSON MICHAEL W | 奖励／授予 (A) | Common Stock | 925 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Johnston Hugh F | 奖励／授予 (A) | Common Stock | 809 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Frist William R | 奖励／授予 (A) | Common Stock, par value $0.01 per share | 809 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | FRIST THOMAS F III | 奖励／授予 (A) | Common Stock, par value $0.01 per share | 1,041 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | DEPARLE NANCY ANN | 奖励／授予 (A) | Common Stock | 509 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | CHIDSEY JOHN | 奖励／授予 (A) | Common Stock | 809 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | McAlevey Michael R | 卖出 (S) | Common Stock | 1,694 | USD 533.37 | USD 903,529 | SEC 申报 ↗ |
| 2026-02-13 | McAlevey Michael R | 期权行权／转换 (M) | Common Stock | 5,000 | USD 236.61 | USD 1,183,050 | SEC 申报 ↗ |
| 2026-02-13 | McAlevey Michael R | 代扣税 (F) | Common Stock | 3,306 | USD 540.29 | USD 1,786,199 | SEC 申报 ↗ |
| 2026-02-11 | Wyatt Christopher F. | 卖出 (S) | Common Stock | 4,000 | USD 505.00 | USD 2,020,000 | SEC 申报 ↗ |
| 2026-02-11 | Berres Jennifer | 卖出 (S) | Common Stock | 8,020 | USD 514.58 | USD 4,126,932 | SEC 申报 ↗ |
| 2026-02-10 | Wyatt Christopher F. | 代扣税 (F) | Common Stock | 1,034 | USD 502.05 | USD 519,120 | SEC 申报 ↗ |
| 2026-02-10 | Wyatt Christopher F. | 奖励／授予 (A) | Common Stock | 3,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Rossitto Erica | 代扣税 (F) | Common Stock | 418 | USD 502.05 | USD 209,857 | SEC 申报 ↗ |
| 2026-02-10 | Rossitto Erica | 奖励／授予 (A) | Common Stock | 1,676 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | McAlevey Michael R | 代扣税 (F) | Common Stock | 3,006 | USD 502.05 | USD 1,509,162 | SEC 申报 ↗ |
| 2026-02-10 | McAlevey Michael R | 奖励／授予 (A) | Common Stock | 8,372 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Marks Mike A | 代扣税 (F) | Common Stock | 1,690 | USD 502.05 | USD 848,464 | SEC 申报 ↗ |
| 2026-02-10 | Marks Mike A | 奖励／授予 (A) | Common Stock | 5,026 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | HAZEN SAMUEL N | 代扣税 (F) | Common Stock | 21,323 | USD 502.05 | USD 10,705,212 | SEC 申报 ↗ |
| 2026-02-10 | HAZEN SAMUEL N | 奖励／授予 (A) | Common Stock | 54,934 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Foster Jon M | 代扣税 (F) | Common Stock | 5,888 | USD 502.05 | USD 2,956,070 | SEC 申报 ↗ |
| 2026-02-10 | Foster Jon M | 奖励／授予 (A) | Common Stock | 15,696 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Cuffe Michael S. | 代扣税 (F) | Common Stock | 3,501 | USD 502.05 | USD 1,757,677 | SEC 申报 ↗ |
| 2026-02-10 | Cuffe Michael S. | 奖励／授予 (A) | Common Stock | 9,628 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-10 | Berres Jennifer | 代扣税 (F) | Common Stock | 2,515 | USD 502.05 | USD 1,262,656 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HCA |
| CIK | 0000860730 |
| 行业 | Healthcare |
| 细分行业 | Medical Care Facilities Yahoo Finance |
| SEC SIC | 8062 Services-General Medical & Surgical Hospitals, NEC |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 880 transaction lines from 2020-01-29 to 2026-08-26 10 P purchase lines · 188 S sale lines · 682 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.